Company or ticker...

Tango Therapeutics

Tango develops targeted cancer medicines using synthetic lethality biology.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

TNGX

4.3B

78.8

n/a

202.82%

Key Facts

M. Cap

PS

PE

YTD

4.3B

78.8

n/a

202.82%

10MA

20MA

50MA

200MA

$TNGX